Biology subjects

Wieder, M.

Publications and source records attributed to Wieder, M..

5 recordsLinked to original sources

bioRxiv2022

Improving Small Molecule pKa Prediction Using Transfer Learning with Graph Neural Networks

Enumerating protonation states and calculating micro-state pKa values of small molecules is an important yet challenging task for lead optimization and molecular modeling. Commercial and non-commercial solutions have notable limitations such as restrictive and expensive licenses, high CPU/GPU hour requirements, or the need for expert knowledge to set up and use. We present a graph neural network model that is trained on 714,906 calculated mico-state pKa predictions from molecules obtained from the ChEMBL database. The model is fine-tuned on a set of 5,994 experimental pKa values significantly improving its performance on two challenging test sets. Combining the graph neural network model with Dimorphite-DL, an open-source program for enumerating ionization states, we have developed the open-source Python package pkasolver, which is able to generate and enumerate protonation states and calculate micro-state pKa values with high accuracy.

biophysics↗

bioRxiv2021

Teaching free energy calculations to learn from experimental data

Alchemical free energy calculations are an important tool in the computational chemistry toolbox, enabling the efficient calculation of quantities critical for drug discovery such as ligand binding affinities, selectivities, and partition coefficients. However, modern alchemical free energy calculations suffer from three significant limitations: (1) modern molecular mechanics force fields are limited in their ability to model complex molecular interactions, (2) classical force fields are unable to treat phenomena that involve rearrangements of chemical bonds, and (3) these calculations are unable to easily learn to improve their performance if readily-available experimental data is available. Here, we show how all three limitations can be overcome through the use of quantum machine learning (QML) potentials capable of accurately modeling quantum chemical energetics even when chemical bonds are made and broken. Because these potentials are based on mathematically convenient deep learning architectures instead of traditional quantum chemical formulations, QML simulations can be run at a fraction of the cost of quantum chemical simulations using modern graphics processing units (GPUs) and machine learning frameworks. We demonstrate that alchemical free energy calculations in explicit solvent are especially simple to implement using QML potentials because these potentials lack singularities and other pathologies typical of molecular mechanics potentials, and that alchemical free energy calculations are highly effective even when bonds are broken or made. Finally, we show how a limited number of experimental free energy measurements can be used to significantly improve the accuracy of computed free energies for unrelated compounds with no significant generalization gap. We illustrate these concepts on the prediction of aqueous tautomer free energies (related to tautomer ratios), which are highly relevant to drug discovery in that more than a quarter of all approved drugs exist as a mixture of tautomers.

biophysics↗

bioRxiv2020

Fitting quantum machine learning potentials to experimental free energy data: Predicting tautomer ratios in solution

The computation of tautomer ratios of druglike molecules is enormously important in computer-aided drug discovery, as over a quarter of all approved drugs can populate multiple tautomeric species in solution. Unfortunately, accurate calculations of aqueous tautomer ratios--the degree to which these species must be penalized in order to correctly account for tautomers in modeling binding for computer-aided drug discovery--is surprisingly diffcult. While quantum chemical approaches to computing aqueous tautomer ratios using continuum solvent models and rigid-rotor harmonic-oscillator thermochemistry are currently state of the art, these methods are still surprisingly inaccurate despite their enormous computational expense. Here, we show that a major source of this inaccuracy lies in the breakdown of the standard approach to accounting for quantum chemical thermochemistry using rigid rotor harmonic oscillator (RRHO) approximations, which are frustrated by the complex conformational landscape introduced by the migration of double bonds, creation of stereocenters, and introduction of multiple conformations separated by low energetic barriers induced by migration of a single proton. Using quantum machine learning (QML) methods that allow us to compute potential energies with quantum chemical accuracy at a fraction of the cost, we show how rigorous relative alchemical free energy calculations can be used to compute tautomer ratios in vacuum free from the limitations introduced by RRHO approximations. Furthermore, since the parameters of QML methods are tunable, we show how we can train these models to correct limitations in the underlying learned quantum chemical potential energy surface using free energies, enabling these methods to learn to generalize tautomer free energies across a broader range of predictions.

biophysics↗

bioRxiv2020

Towards chemical accuracy for alchemical free energy calculations with hybrid physics-based machine learning / molecular mechanics potentials

Alchemical free energy methods with molecular mechanics (MM) force fields are now widely used in the prioritization of small molecules for synthesis in structure-enabled drug discovery projects because of their ability to deliver 1-2 kcal mol-1 accuracy in well-behaved protein-ligand systems. Surpassing this accuracy limit would significantly reduce the number of compounds that must be synthesized to achieve desired potencies and selectivities in drug design campaigns. However, MM force fields pose a challenge to achieving higher accuracy due to their inability to capture the intricate atomic interactions of the physical systems they model. A major limitation is the accuracy with which ligand intramolecular energetics--especially torsions--can be modeled, as poor modeling of torsional profiles and coupling with other valence degrees of freedom can have a significant impact on binding free energies. Here, we demonstrate how a new generation of hybrid machine learning / molecular mechanics (ML/MM) potentials can deliver significant accuracy improvements in modeling protein-ligand binding affinities. Using a nonequilibrium perturbation approach, we can correct a standard, GPU-accelerated MM alchemical free energy calculation in a simple post-processing step to efficiently recover ML/MM free energies and deliver a significant accuracy improvement with small additional computational effort. To demonstrate the utility of ML/MM free energy calculations, we apply this approach to a benchmark system for predicting kinase:inhibitor binding affinities--a congeneric ligand series for non-receptor tyrosine kinase TYK2 (Tyk2)--wherein state-of-the-art MM free energy calculations (with OPLS2.1) achieve inaccuracies of 0.93{+/-}0.12 kcal mol-1 in predicting absolute binding free energies. Applying an ML/MM hybrid potential based on the ANI2x ML model and AMBER14SB/TIP3P with the OpenFF 1.0.0 ("Parsley") small molecule force field as an MM model, we show that it is possible to significantly reduce the error in absolute binding free energies from 0.97 [95% CI: 0.68, 1.21] kcal mol-1 (MM) to 0.47 [95% CI: 0.31, 0.63] kcal mol-1 (ML/MM).

biophysics↗

bioRxiv2019

Computational identification of novel Kir6 channel inhibitors

KATP channels consist of four Kir6.x pore-forming subunits and four regulatory sulfonylurea receptor (SUR) subunits. These channels couple the metabolic state of the cell to membrane excitability and play a key role in physiological processes such as insulin secretion in the pancreas, protection of cardiac muscle during ischemia and hypoxic vasodilation of arterial smooth muscle cells. Abnormal channel function resulting from inherited gain or loss-of-function mutations in either the Kir6.x and/or SUR subunits are associated with severe diseases such as neonatal diabetes, congenital hyperinsulinism or Cantu syndrome (CS). CS is an ultra-rare genetic autosomal dominant disorder, caused by dominant gain-of-function mutations in SUR2A or Kir6.1 subunits. No specific pharmacotherapeutic treatment options are currently available for Cantu syndrome. Kir6 specific inhibitors could be beneficial for the development of novel drug therapies for Cantu syndrome, particular for mutations, which lack high affinity for sulfonylurea inhibitor glibenclamide. By applying a combination of computational methods including atomistic MD simulations, free energy calculations and pharmacophore modelling, we identified several novel Kir6.1 inhibitors, which might be possible candidates for drug repurposing. The in silico predictions were confirmed using inside/out patch-clamp analysis. Importantly, Cantu mutation C176S in Kir6.1 and S1020P in SUR2A, retained high affinity towards the novel inhibitors. Summarizing, the inhibitors identified in this study might provide a starting point towards developing novel therapies for Cantu disease.

pharmacology and toxicology↗